{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:01:36Z","timestamp":1781888496858,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1136\/ard.2007.069518","type":"journal-article","created":{"date-parts":[[2007,5,8]],"date-time":"2007-05-08T00:13:10Z","timestamp":1178583190000},"page":"1641-1647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis"],"prefix":"10.1016","volume":"66","author":[{"given":"Philip J","family":"Clements","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P","family":"Tashkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mildred","family":"Sterz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R","family":"Seibold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Schraufnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcy","family":"Bolster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D","family":"Mayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Metersky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E","family":"Furst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.069518_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069518_bib2","series-title":"Systemic sclerosis","first-page":"129","article-title":"Cutaneous involvement","author":"Clements","year":"2004"},{"key":"10.1136\/ard.2007.069518_bib3","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069518_bib4","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069518_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-132-12-200006200-00004","article-title":"Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis","volume":"132","author":"White","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2007.069518_bib6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00002281-200311000-00011","article-title":"Evaluation and management of alveolitis and interstitial lung disease in scleroderma","volume":"15","author":"Latsi","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.2007.069518_bib7","first-page":"838","article-title":"Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease","volume":"20","author":"Silver","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.069518_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780370518","article-title":"Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide","volume":"37","author":"Akesson","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069518_bib9","first-page":"731","article-title":"Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis","volume":"29","author":"Giacomelli","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.069518_bib10","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1136\/ard.2007.069518_bib11","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/art.22204","article-title":"A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma","volume":"54","author":"Hoyles","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069518_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1378\/chest.85.6.751","article-title":"The measurement of dyspnea: contents, interobserver agreement and physiologic correlates of two new clinical indexes","volume":"85","author":"Mahler","year":"1984","journal-title":"Chest"},{"key":"10.1136\/ard.2007.069518_bib13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","article-title":"Standardization of spirometry\u20141994 update","volume":"152","year":"1995","journal-title":"Am Rev Respir Dis"},{"key":"10.1136\/ard.2007.069518_bib14","first-page":"1184","volume":"39","year":"1994","journal-title":"Respir Care"},{"key":"10.1136\/ard.2007.069518_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0954-6111(05)80346-4","article-title":"Guidelines for the measurement of respiratory function: recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists","volume":"88","year":"1994","journal-title":"Respir Med"},{"key":"10.1136\/ard.2007.069518_bib16","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1164\/ajrccm.152.6.8520796","article-title":"Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique\u20141995 update","volume":"152","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard.2007.069518_bib17","first-page":"696","article-title":"Maximal respiratory pressures: normal values and relationship to age and sex","volume":"99","author":"Black","year":"1969","journal-title":"Am Rev Respir Dis"},{"key":"10.1136\/ard.2007.069518_bib18","first-page":"659","article-title":"Reference spirometric values using techniques and equipment that meet ATS recommendations","volume":"123","author":"Crapo","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"10.1136\/ard.2007.069518_bib19","first-page":"419","article-title":"Lung volumes in healthy nonsmoking adults","volume":"18","author":"Crapo","year":"1982","journal-title":"Bull Eur Physiopathol Respir"},{"key":"10.1136\/ard.2007.069518_bib20","first-page":"185","article-title":"Standardized single breath normal values of carbon monoxide diffusing capacity","volume":"123","author":"Crapo","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"10.1136\/ard.2007.069518_bib21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1164\/ajrccm\/144.5.1202","article-title":"Lung function testing: Selection of reference values and interpretative strategies","volume":"144","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1136\/ard.2007.069518_bib22","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/art.20265","article-title":"Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography in dyspnea patients with systemic sclerosis (scleroderma)","volume":"50","author":"Clements","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069518_bib23","first-page":"A105","article-title":"High resolution CT findings in scleroderma-related lung diseases","author":"Goldin","year":"2006","journal-title":"Proceedings of ATS"},{"key":"10.1136\/ard.2007.069518_bib24","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.1780401110","article-title":"The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069518_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1136\/ard.2007.069518_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1378\/chest.97.1.75","article-title":"The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis","volume":"98","author":"Petty","year":"1990","journal-title":"Chest"},{"key":"10.1136\/ard.2007.069518_bib27","unstructured":"Elashoff RM, Li G, Li N,. An approach to joint analysis of longitudinal measurements and competing risks failure time data., Statist Med. In press."},{"key":"10.1136\/ard.2007.069518_bib28","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.069518_bib29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/rheumatology\/keh253","article-title":"Prevalence of systemic sclerosis in a French multi-ethnic county","volume":"43","author":"Le Guern","year":"2004","journal-title":"Rheumatology (Oxford)"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724345923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724345923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.069518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:01:41Z","timestamp":1737356501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724345923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0003496724345923"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.069518","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.069518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 2007 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}